The plasma level of IL-6, a significant cytokine contributing to macrophage activation syndrome (MAS), which is also known as a form of CRS, has been shown to increase in both mild and severe COVID-19 patients (1, 5, 6, 39). This evidence concerns the gene IL6 and macrophage activation syndrome.